VY-AADC02

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VY-AADC02, covering 2024-12-10 to 2024-12-10. Get the full timeline:

Most recent: Clinical Trial Update: VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1) [Phase 1]